4-ethyl-N-(3-(7-(4-fluorophenyl)-3-hydroxy-4-oxo-chromen-2-yl)phenyl)benzamide

ID: ALA5207930

Chembl Id: CHEMBL5207930

PubChem CID: 168295473

Max Phase: Preclinical

Molecular Formula: C30H22FNO4

Molecular Weight: 479.51

Names and Identifiers

Canonical SMILES:  CCc1ccc(C(=O)Nc2cccc(-c3oc4cc(-c5ccc(F)cc5)ccc4c(=O)c3O)c2)cc1

Standard InChI:  InChI=1S/C30H22FNO4/c1-2-18-6-8-20(9-7-18)30(35)32-24-5-3-4-22(16-24)29-28(34)27(33)25-15-12-21(17-26(25)36-29)19-10-13-23(31)14-11-19/h3-17,34H,2H2,1H3,(H,32,35)

Standard InChI Key:  OTOABUQDIDJYPM-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5207930

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 479.51

Molecular Weight (Monoisotopic): 479.1533

AlogP: 6.79

#Rotatable Bonds: 5

Polar Surface Area: 79.54

Molecular Species: NEUTRAL

HBA: 4

HBD: 2

#RO5 Violations: 1

HBA (Lipinski): 5

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 9.21

CX Basic pKa: ┄

CX LogP: 6.56

CX LogD: 6.55

Aromatic Rings: 5

Heavy Atoms: 36

QED Weighted: 0.29

Np Likeness Score: -0.60

References

1. Zha D, Li Y, Luo Y, Liu Y, Lin Z, Lin C, Chen S, Wu J, Yu L, Chen S, Zhang P, Wu W, Zhang C..  (2022)  Synthesis and in vitro anticancer evaluation of novel flavonoid-based amide derivatives as regulators of the PI3K/AKT signal pathway for TNBC treatment.,  13  (9.0): [PMID:36324491] [10.1039/d2md00148a]

Source

Source(1):

• Scientific Literature